Bio-Techne Corporation (FRA:TE1)

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of EUR 7.64 billion. The enterprise value is 7.78 billion.

Market Cap	7.64B
Enterprise Value	7.78B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	156.45M
Shares Outstanding	n/a
Shares Change (YoY)	-2.20%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	154.58M

Valuation Ratios

The trailing PE ratio is 110.64 and the forward PE ratio is 27.62.

PE Ratio	110.64
Forward PE	27.62
PS Ratio	7.38
PB Ratio	4.46
P/TBV Ratio	12.90
P/FCF Ratio	40.21
P/OCF Ratio	35.97
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.88, with an EV/FCF ratio of 40.98.

EV / Earnings	112.75
EV / Sales	7.54
EV / EBITDA	25.88
EV / EBIT	33.75
EV / FCF	40.98

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.17.

Current Ratio	4.54
Quick Ratio	2.59
Debt / Equity	0.17
Debt / EBITDA	0.99
Debt / FCF	1.57
Interest Coverage	29.15

Financial Efficiency

Return on equity (ROE) is 3.97% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	3.97%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	8.75%
Return on Capital Employed (ROCE)	11.37%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	333,970
Profits Per Employee	22,271
Employee Count	3,100
Asset Turnover	0.47
Inventory Turnover	2.06

Taxes

In the past 12 months, Bio-Techne has paid 28.18 million in taxes.

Income Tax	28.18M
Effective Tax Rate	28.98%

Stock Price Statistics

The stock price has decreased by -23.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.17%
50-Day Moving Average	53.36
200-Day Moving Average	48.73
Relative Strength Index (RSI)	35.17
Average Volume (20 Days)	5

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.61

Income Statement

In the last 12 months, Bio-Techne had revenue of EUR 1.04 billion and earned 69.04 million in profits. Earnings per share was 0.44.

Revenue	1.04B
Gross Profit	689.57M
Operating Income	230.65M
Pretax Income	97.26M
Net Income	69.04M
EBITDA	281.52M
EBIT	230.65M
Earnings Per Share (EPS)	0.44

Balance Sheet

The company has 152.92 million in cash and 298.86 million in debt, with a net cash position of -145.94 million.

Cash & Cash Equivalents	152.92M
Total Debt	298.86M
Net Cash	-145.94M
Net Cash Per Share	n/a
Equity (Book Value)	1.71B
Book Value Per Share	10.99
Working Capital	423.30M

Cash Flow

In the last 12 months, operating cash flow was 212.34 million and capital expenditures -22.40 million, giving a free cash flow of 189.95 million.

Operating Cash Flow	212.34M
Capital Expenditures	-22.40M
Free Cash Flow	189.95M
FCF Per Share	n/a

Margins

Gross margin is 66.60%, with operating and profit margins of 22.28% and 6.67%.

Gross Margin	66.60%
Operating Margin	22.28%
Pretax Margin	9.39%
Profit Margin	6.67%
EBITDA Margin	27.19%
EBIT Margin	22.28%
FCF Margin	18.35%

Dividends & Yields

This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 0.57%.

Dividend Per Share	0.28
Dividend Yield	0.57%
Dividend Growth (YoY)	-7.19%
Years of Dividend Growth	n/a
Payout Ratio	62.49%
Buyback Yield	2.20%
Shareholder Yield	2.77%
Earnings Yield	0.90%
FCF Yield	2.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 30, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio-Techne has an Altman Z-Score of 12.36 and a Piotroski F-Score of 8.

Altman Z-Score	12.36
Piotroski F-Score	8